RECRUITING

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.

Official Title

INST UNM 1521: Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Quick Facts

Study Start:2016-01-27
Study Completion:2037-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03977402

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age and older.
  2. * Has a diagnosis of cancer or is suspected of having cancer.
  3. * Able to understand and sign the Informed Consent form directly.
  4. * Pregnant women are permitted to be enrolled.
  1. * Prisoners

Contacts and Locations

Study Contact

Christine Serway, PhD
CONTACT
505-272-2412
CSerway@salud.unm.edu
Ellen Wojcik, MBA-HCM
CONTACT
ewojcik@salud.unm.edu

Principal Investigator

Leslie Andritsos, MD
PRINCIPAL_INVESTIGATOR
University of New Mexico Cancer Center

Study Locations (Sites)

University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, 87102
United States

Collaborators and Investigators

Sponsor: New Mexico Cancer Care Alliance

  • Leslie Andritsos, MD, PRINCIPAL_INVESTIGATOR, University of New Mexico Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2016-01-27
Study Completion Date2037-12-31

Study Record Updates

Study Start Date2016-01-27
Study Completion Date2037-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Cancer
  • Cancer Risk